Ischaemic brain damage after stroke: new insights into efficient therapeutic strategies. International Symposium on Neurodegeneration and Neuroprotection.
Culmsee
Carsten
C
Pharmazeutische Biologie-Biotechnologie, Department Pharmazie, Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13D, D-81377 München, Germany. carsten.culmsee@cup.uni-muenchen.de
Krieglstein
Josef
J
D017209:Apoptosis / Q000502:physiology*; D002545:Brain Ischemia / Q000209:etiology* / Q000276:immunology / Q000503:physiopathology* / Q000628:therapy*; D002118:Calcium / Q000378:metabolism; D006801:Humans; D008954:Models, Biological; D009474:Neurons / Q000166:cytology*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010766:Phosphorylation; D011506:Proteins / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D020521:Stroke / Q000150:complications*
D018696:Neuroprotective Agents; D011506:Proteins; D017382:Reactive Oxygen Species; D002118:Calcium